Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2017

Aug 4, 2017

32337_dirs_2017-08-04_c322a386-5f09-4a49-a282-b13e91825762.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2017-08-01

Reporting Person: Schissel Mark J (EVP, WW Operations)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1200 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Right $79.58 2023-12-19 Common Stock (6809) Direct
Stock Appreciation Right $59.98 2024-04-30 Common Stock (8631) Direct
Stock Appreciation Right $30.44 2025-03-02 Common Stock (8442) Direct
Stock Appreciation Right $62.51 2026-05-09 Common Stock (6298) Direct
Stock Appreciation Right $57.19 2027-02-27 Common Stock (6091) Direct

Footnotes

F1: On December 19, 2013, the reporting person was granted 6,809 Stock Appreciation Rights ("SARs"). These SARs were fully as of December 19, 2016.

F2: On April 30, 2014, the reporting person was granted 8,631 SARs. These SARs were fully vested as of April 30, 2017.

F3: On March 2, 2015, the reporting person was granted 14,070 SARs. Forty percent (40%) of these SARs were vested as of March 2, 2017, and the remaining sixty percent (60%) will vest on March 2, 2018.

F4: On May 9, 2016, the reporting person was granted 6,298 SARs. Twenty percent (20%) of these SARs were vested as of May 9, 2017, twenty percent (20%) will vest on May 9, 2018, and the remaining sixty percent (60%) will vest on May 9, 2019.

F5: On February 27, 2017, the reporting person was granted 6,091 SARs. Twenty percent (20%) of these SARs will vest each on February 27, 2018 and February 27, 2019, and the remaining sixty percent (60%) will vest on February 27, 2020.